BioPharm America™ is where biotech industry partnerships get started. This three-day conference provides a proven and highly productive format for establishing new business relationships. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, the world’s leading web-based partnering system for the life science industry, BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®. In 2014, BioPharm America attracted 850+ delegates from over 500 companies who participated in 2350+ scheduled one-to-one meetings.
Register online using the link below. To receive your Maine Bioscience discount of USD 200 please e-mail firstname.lastname@example.org to receive a discount code. Discounts will not be applied retroactively and must be noted at the time of registration.
A new program is being launched in Bangor, Maine, to help early stage companies test, improve and figure out how to commercialize their ideas in a short time frame. Scratchpad is a seed accelerator that will allow entrepreneurs fully commit to developing their business fast and with no distractions. The applicants need to have a team of 2-3 people working on their startup full time for a period of 3 months and need to be in Bangor for that time. The awarded will be given funding, daily access to coaches, problem solvers and mentors. The program starts the week of August 31 and the application deadline is August 28. The Scratchpad Accelerator is a University of Maine initiative in collaboration with the Maine Technology Institute. To learn on the application process, please go here. If you are part of an established company and interested in becoming a mentor, please go here.
Seth Berry, a former Maine Legislator and majority leader is transitioning into private sector with Kennebec River Biosciences, Mainebiz reports. Mr. Berry served in the Maine Legislature for eight years (2006–14). In January, Berry was hired by Richmond-based Kennebec River Biosciences as vice president for international business development. "It's really an exciting space, the innovation that's happening in Maine, just as it is in Silicon Valley or the beltway in Boston. Maine is clearly doing some great things" said Mr. Berry. Read full story here
Available through the U.S Department of Labor, the Make It In America Grant provides funds for incumbent workers' training for biotech companies in 8 Maine counties: York, Sagadahoc, Kennebec, Cumberland, Lincoln, Androscoggin, Waldo and Knox. Training must result in an industry-recognized credential within the industry sector for the employee.
The House passed legislation Friday that aims to speed the development of new drugs and medical devices by increasing health research funding and streamlining the approval process for new treatments. The bill, called 21st Century Cures, was cheered by rare across-the-aisle support from politicians, with 230 co-sponsors nearly evenly split between Democrats and Republicans. The pharmaceutical industry, Biotechnology Industry Organization, patient advocacy groups, and medical organizations also support the bill, which calls for an additional $8.75 billion for the National Institutes of Health. Now the debate on whether the benefits of this legislation are worth its risks moves to the Senate. Read full story
Mount Desert Island Biological Laboratory in Bar Harbor is receiving a $392,463 federal grant to support research for treatment of various diseases, including Alzheimer's and Parkinson's. "This funding will support the laboratory as it strives to develop medications and treatments for diseases affecting countless Americans and their families every day." U.S. Sens. Suzan Collins and Angus King said in a joint statement. Read full story
Bioscience Association of Maine (BAM), in collaboration with Bioscience Industry Organization (BIO) is proud to announce that 2 new partners have been added to its cost savings program. The new offerings include savings on executive liability insurance through AON Risk Solutions, and environmental waste services through Clean Harbors. BAM members will now be able to obtain significant discounts on services. Read full story
The Maine Technology Institute (MTI) approved four new awards from its Cluster Initiative Program (CIP) for collaborative projects that boost Maine’s high-potential technology-intensive clusters. The awards were given to TechPlace at Brunswick Landing, the University of Southern Maine Cybersecurity Cluster, the Composites Engineering and Research Lab at Southern Maine Community College and the Forest Bioproducts Research Institute at the University of Maine at Orono. “These projects will enhance collaboration and innovation between public and private sector entities and will lead to the development of new businesses, products, processes, skilled workforce, and jobs.” Said Brian Whitney, MTI’s president. Read full story
The Advanced Medical Technology Association (AdvaMed), the Medical Device Manufacturers Association (MDMA) and the Medical Imaging & Technology Alliance (MITA), a division of National Electrical Manufacturers Association (NEMA), commended the House of Representatives for passing legislation to repeal the medical device excise tax. The legislation, H.R. 160 "The Protect Medical Innovation Act," passed with a vote of 280 to 140 on Thursday, June 18. "For far too long, the medical device tax has stymied advancements in patient care and destroyed high tech manufacturing jobs. Repealing this policy will provide an immediate boost for medical technology innovators to continue solving the pressing challenges in the health care ecosystem. MDMA and the broad coalition of stakeholders who have worked tirelessly to repeal the medical device tax will not rest until we get this accomplished once and for all." said Mark Leahey, President and CEO of MDMA. Read full story here
The Bioscience Association of Maine strongly opposes LD 1422, “An Act To Allow Maine Residents To Personally Import Medications as Permitted under the Federal Food, Drug, and Cosmetic Act”. This legislation, if passed, will present a great risk to the public health of Maine residents and will also open the State of Maine to additional costly and unnecessary litigation. BAM is of the opinion that the legislation outlined in LD 1422 is misguided and we feel inappropriately addresses the issue it purportedly seeks to remedy. Read full statement here
Maine Medical Research Center in Scarborough has attracted acclaimed scientists lately, some bringing grants with them, MaineBiz reports. One scientist is Dr. Peter Brooks, who after years of research on cell and cancer growth at prestigious research institutes around the US, decided to go back to his Maine roots in 2007 and continues his work at MMRCI as a senior researcher and lab head. "I always wanted to do research here in Maine. The biomedical research environment here is growing now. Some 10 to 15 years ago I questioned it,” said Dr. Brooks. Another top class researcher who is joining MMRCI this September is a Harvard Medical School postdoctoral candidate, Dr. Michaela Reagan, whose work focuses on multiple myeloma. Dr. Reagan t, who had never been to Maine prior to accepting the position, is bringing grant money with her which is great news for MMCRI’s PI’s who must raise all of the money to run labs. Read full story
The new business incubator TechPlace is already home to 15 tenants, one day before its Grand Opening on May 28 and 5 months into operations, MaineBiz says. TechPlace, Brunswick Landing’s Technology Accelerator, features 50,000 square foot manufacturing space (enough for 25 companies) and 20,000 square foot office space (room for 23 companies).. The incubator is designed for startups in the aerospace, aviation, biotechnology, renewable energy, composites and advanced materials and IT sectors. Kristine Schuman, business development coordinator for Midcoast Regional Redevelopment Authority, said that “most of the tenants have one-year leases, but they're able to leave at any time with a month's notice and without financial penalty. The benefit is aimed to give startups and early-stage companies a little leeway if things don't go as planned.” Read full story
Three bioscience-focused non-profits collaborate to stimulate Maine’s biotech industry, MaineBiz reports. The new collaborative, known as Life Sciences Group (LSG), includes MDI Biological Laboratory in Salisbury Cove, Bigelow Laboratory for Ocean Sciences in East Boothbay and the Foundation for Blood Research in Scarborough. The idea behind LSG is to attract outside investment and entrepreneurial spirit to Maine. Jane Sheehan, President and CEO of the Foundation for Blood Research, says "The three institutions want to convert science to more of a commercial purpose, keep it in the state and work together as a catalyst for economic growth". Read Full Story
Members of the Bioscience Association of Maine who may need support in a variety of core research areas will find that they do not need to travel out of state to access world-class scientists at very competitive pricing. Todd Keiller, Director of Technology Transfer at MMCRI and Claire Deselle, Executive Director of BAM, discussed the advantages and the opportunity in the following interview.
360 Binney Street
Cambridge, MA 02142